Page 2596 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 159 Hematologic Problems in the Surgical Patient 2312.e1

REFERENCES 25. Hayward CP, Harrison P, Cattaneo M, et al: Platelet function analyzer
(PFA)-100 closure time in the evaluation of platelet disorders and
1. Sramek A, Eikenboom JC, Briet E, et al: Usefulness of patient interview platelet function. J Thromb Haemost 4:312–319, 2006.
in bleeding disorders. Arch Intern Med 155:1409–1415, 1995. 26. Harrison P: The role of PFA-100 testing in the investigation and man-
2. Gabriel P, Mazoit X, Ecoffey C: Relationship between clinical history, agement of haemostatic defects in children and adults. Br J Haematol
coagulation tests, and perioperative bleeding during tonsillectomies in 130:3–10, 2005.
pediatrics. J Clin Anesth 12:288–291, 2000. 27. Roschitz B, Thaller S, Koestenberger M, et al: PFA-100 closure times
3. Mauser Bunschoten EP, van Houwelingen JC, Sjamsoedin Visser EJ, in preoperative screening in 500 pediatric patients. Thromb Hemost
et al: Bleeding symptoms in carriers of hemophilia A and B. Thromb 98:243–247, 2007.
Hemost 59:349–352, 1988. 28. Gianetti J, Parri MS, Sbrana S, et al: Platelet activation predicts
4. Nosek-Cenkowska B, Cheang MS, Pizzi NJ, et al: Bleeding/bruising recurrent ischemic events after percutaneous coronary angioplasty: a 6
symptomatology in children with and without bleeding disorders. months prospective study. Thromb Res 118:487–493, 2006.
Thromb Hemost 65:237–241, 1991. 29. Bevilacqua S, Alkodami AA, Volpi E, et al: Risk stratification after
5. Bowie EJ, Owen CA, Jr: The significance of abnormal preoperative coronary artery bypass surgery by a point-of-care test of platelet func-
hemostatic tests. Prog Hemost Thromb 5:179–209, 1980. tion. Ann Thorac Surg 87:496–502, 2009.
6. Burk CD, Miller L, Handler SD, et al: Preoperative history and 30. Fattorutto M, Pradier O, Schmartz D, et al: Does the platelet function
coagulation screening in children undergoing tonsillectomy. Pediatrics analyser (PFA-100) predict blood loss after cardiopulmonary bypass? Br
89:691–695, 1992. J Anaesth 90:692–693, 2003.
7. Rapaport SI: Preoperative hemostatic evaluation: which tests, if any? 31. Cammerer U, Dietrich W, Rampf T, et al: The predictive value of
Blood 61:229–231, 1983. modified computerized thromboelastography and platelet function
8. Dorman BH, Spinale FG, Bailey MK, et al: Identification of patients analysis for postoperative blood loss in routine cardiac surgery. Anesth
at risk for excessive blood loss during coronary artery bypass surgery: Analg 96:51–57, 2003. table of contents.
thromboelastography versus coagulation screen. Anesth Analg 76:694– 32. Thaler HW, Frisee F, Korninger C: Platelet aggregation inhibitors,
700, 1993. platelet function testing, and blood loss in hip fracture surgery. J
9. Suchman AL, Griner PF: Diagnostic uses of the activated partial throm- Trauma 69:1217–1220, discussion 21, 2010.
boplastin time and prothrombin time. Ann Int Med 104:810–816, 33. Levy JH: Hemostatic agents. Transfusion 44:58s–62s, 2004.
1986. 34. Mannucci PM, Levi M: Prevention and treatment of major blood loss.
10. Eisenberg JM, Clarke JR, Sussman SA: Prothrombin and partial throm- N Engl J Med 356:2301–2311, 2007.
boplastin times as preoperative screening tests. Arch Surg 117:48–51, 35. Mannucci PM, Ghirardini A: Desmopressin: twenty years after. Thromb
1982. Hemost 78:958, 1997.
11. Kaplan EB, Sheiner LB, Boeckmann AJ, et al: The usefulness of 36. Mannucci PM: Hemostatic drugs. N Engl J Med 339:245–253, 1998.
preoperative laboratory screening. JAMA 253:3576–3581, 1985. 37. Mannucci PM, Bettega D, Cattaneo M: Patterns of development
12. Segal JB, Dzik WH: Paucity of studies to support that abnormal coagu- of tachyphylaxis in patients with haemophilia and von Willebrand
lation test results predict bleeding in the setting of invasive procedures: disease after repeated doses of desmopressin (DDAVP). Br J Haematol
an evidence-based review. Transfusion 45:1413–1425, 2005. 82:87–93, 1992.
13. Ng KF, Lai KW, Tsang SF: Value of preoperative coagulation tests: 38. Porte RJ, Leebeek FW: Pharmacological strategies to decrease transfu-
reappraisal of major noncardiac surgery. World J Surg 26:515–520, sion requirements in patients undergoing surgery. Drugs 62:2193–2211,
2002. 2002.
14. Kitchens CS: To bleed or not to bleed? Is that the question for the PTT? 39. Norfolk DR, Seghatchian J: Pharmacological therapies to minimise
J Thromb Haemost 3:2607–2611, 2005. platelet transfusion. Transfus Sci 22:149–153, 2000.
15. Close HL, Kryzer TC, Nowlin JH, et al: Hemostatic assessment of 40. Cattaneo M, Harris AS, Stromberg U, et al: The effect of desmo-
patients before tonsillectomy: a prospective study. Otolaryngol Head pressin on reducing blood loss in cardiac surgery–a meta-analysis of
Neck Surg 111:733–738, 1994. double-blind, placebo-controlled trials. Thromb Hemost 74:1064–1070,
16. Gravlee GP, Arora S, Lavender SW, et al: Predictive value of blood 1995.
clotting tests in cardiac surgical patients. Ann Thorac Surg 58:216–221, 41. Levi M, Cromheecke ME, de Jonge E, et al: Pharmacological strategies
1994. to decrease excessive blood loss in cardiac surgery: a meta-analysis of
17. Houry S, Georgeac C, Hay JM, et al: A prospective multicenter evalua- clinically relevant endpoints. Lancet 354:1940–1947, 1999.
tion of preoperative hemostatic screening tests. The French Associations 42. Ozier Y, Schlumberger S: Pharmacological approaches to reducing
for Surgical Research. Am J Surg 170:19–23, 1995. blood loss and transfusions in the surgical patient. Can J Anaesth
18. Macpherson CR, Jacobs P, Dent DM: Abnormal peri-operative haem- 53:S21–S29, 2006.
orrhage in asymptomatic patients is not predicted by laboratory testing. 43. Crescenzi G, Landoni G, Biondi-Zoccai G, et al: Desmopressin reduces
S Afr Med J 83:106–108, 1993. transfusion needs after surgery: a meta-analysis of randomized clinical
19. Myers ER, Clarke-Pearson DL, Olt GJ, et al: Preoperative coagulation trials. Anesthesiology 109:1063–1076, 2008.
testing on a gynecologic oncology service. Obstet Gynecol 83:438–444, 44. Steinlechner B, Zeidler P, Base E, et al: Patients with severe aortic
1994. valve stenosis and impaired platelet function benefit from preoperative
20. Eckman MH, Erban JK, Singh SK, et al: Screening for the risk for desmopressin infusion. Ann Thorac Surg 91:1420–1426, 2011.
bleeding or thrombosis. Ann Int Med 138:W15–W24, 2003. 45. Lowe GD: Desmopressin and myocardial infarction. Lancet 1:895–896,
21. Chee YL, Crawford JC, Watson HG, et al: Guidelines on the assess- 1989.
ment of bleeding risk prior to surgery or invasive procedures. British 46. Achneck HE, Sileshi B, Jamiolkowski RM, et al: A comprehensive
Committee for Standards in Haematology. Br J Haematol 140:496–504, review of topical hemostatic agents: efficacy and recommendations for
2008. use. Ann Surg 251:217–228, 2010.
22. Carcao MD, Blanchette VS, Stephens D, et al: Assessment of throm- 47. Streiff MB, Ness PM: Acquired FV inhibitors: a needless iatrogenic
bocytopenic disorders using the Platelet Function Analyzer (PFA-100). complication of bovine thrombin exposure. Transfusion 42:18–26,
Br J Haematol 117:961–964, 2002. 2002.
23. Jilma B: Platelet function analyzer (PFA-100): a tool to quantify con- 48. Ortel TL, Mercer MC, Thames EH, et al: Immunologic impact and
genital or acquired platelet dysfunction. J Lab Clin Med 138:152–163, clinical outcomes after surgical exposure to bovine thrombin. Ann Surg
2001. 233:88–96, 2001.
24. Mammen EF, Comp PC, Gosselin R, et al: PFA-100 system: a new 49. Sarfati MR, Dilorenzo DJ, Kraiss LW, et al: Severe coagulopathy follow-
method for assessment of platelet dysfunction. Semin Thromb Hemost ing intraoperative use of topical thrombin. Ann Vasc Surg 18:349–351,
24:195–202, 1998. 2004.